{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:00:54Z","timestamp":1768446054700,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11442-5","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:13:05Z","timestamp":1768313585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression"],"prefix":"10.1007","volume":"53","author":[{"given":"Khaoula","family":"Elghazali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouad","family":"Najih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"zineb","family":"Sakhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelilah","family":"Laaraqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rida","family":"Tagajdid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdessamad","family":"Amine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moulay Mustapha","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"1\u20132","key":"11442_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000477852","volume":"85","author":"Y Tolkach","year":"2018","unstructured":"Tolkach Y, Kristiansen G (2018) The heterogeneity of prostate cancer: A practical approach. Pathobiology 31 Janv 85(1\u20132):108\u2013116","journal-title":"Pathobiology 31 Janv"},{"issue":"2","key":"11442_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI et al (2021) Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol f\u00e9vr 18(2):79\u201392","journal-title":"Nat Rev Urol f\u00e9vr"},{"key":"11442_CR3","doi-asserted-by":"publisher","unstructured":"Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer | Molecular Biology Reports [Internet]. [cit\u00e9 15 oct 2025]. Disponible sur: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s11033-014-3491-0","DOI":"10.1007\/s11033-014-3491-0"},{"issue":"3","key":"11442_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer EJ, Laversanne M, Sung H, Soerjomataram I, Briganti A, Dahut W et al (2025) Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol Mars 87(3):302\u2013313","journal-title":"Eur Urol Mars"},{"issue":"2","key":"11442_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol Avr 10(2):63\u201389","journal-title":"World J Oncol Avr"},{"issue":"3","key":"11442_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/geno.1997.4845","volume":"44","author":"A Paoloni-Giacobino","year":"1997","unstructured":"Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE (1997) Cloning of the TMPRSS2 gene, which encodes a novel Serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 15 Sept 44(3):309\u2013320","journal-title":"Genomics 15 Sept"},{"issue":"4","key":"11442_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.prnil.2018.03.004","volume":"6","author":"A Bhanushali","year":"2018","unstructured":"Bhanushali A, Rao P, Raman V, Kokate P, Ambekar A, Mandva S et al (2018) Status of TMPRSS2-ERG fusion in prostate cancer patients from india: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism. Prostate Int d\u00e9c 6(4):145\u2013150","journal-title":"Prostate Int d\u00e9c"},{"issue":"2","key":"11442_CR8","doi-asserted-by":"publisher","first-page":"e86824","DOI":"10.1371\/journal.pone.0086824","volume":"9","author":"C H\u00e4ggl\u00f6f","year":"2014","unstructured":"H\u00e4ggl\u00f6f C, Hammarsten P, Str\u00f6mvall K, Egevad L, Josefsson A, Stattin P et al (2014) TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLOS ONE 5 f\u00e9vr 9(2):e86824","journal-title":"PLOS ONE 5 f\u00e9vr"},{"issue":"12","key":"11442_CR9","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/sj.bjc.6604054","volume":"97","author":"RK Nam","year":"2007","unstructured":"Nam RK, Sugar L, Yang W, Srivastava S, Klotz LH, Yang LY et al (2007) Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer d\u00e9c 97(12):1690\u20131695","journal-title":"Br J Cancer d\u00e9c"},{"key":"11442_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2407-8-230","volume":"8","author":"LM FitzGerald","year":"2008","unstructured":"FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A et al (2008) Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMC Cancer 11 ao\u00fbt 8:230","journal-title":"BMC Cancer 11 ao\u00fbt"},{"issue":"1","key":"11442_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11033-025-10662-5","volume":"52","author":"F Sertgoz","year":"2025","unstructured":"Sertgoz F, Efiloglu O, Nikerel E, Yildirim A, Telci D (2025) Role of Rs228648 and Rs2890565 single nucleotide polymorphisms in Urotensin-2 gene in prostate cancer. Mol Biol Rep 9 Juin 52(1):572","journal-title":"Mol Biol Rep 9 Juin"},{"key":"11442_CR12","doi-asserted-by":"crossref","unstructured":"Sadiq S, Abbasi S, Rehman B, Ikram S, Shahzad A, Kohistani TA, ASSOCIATION OF SMOKING WITH PROSTATE CANCER IN OLD AGE PAKISTANI MALES WITH TMPRSS2 GENE POLYMORPHISM (2024) rs12329760). Pakistan Journal of Physiology. 30 juin. ;20(2):54\u20137","DOI":"10.69656\/pjp.v20i2.1656"},{"issue":"1","key":"11442_CR13","first-page":"e2023030","volume":"94","author":"O Izmailova","year":"2023","unstructured":"Izmailova O, Shlykova O, Kabaliei A, Vatsenko A, Ivashchenko D, Dudchenko M et al (2023) Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population. Acta Biomed 94(1):e2023030","journal-title":"Acta Biomed"},{"key":"11442_CR14","doi-asserted-by":"publisher","unstructured":"Sekiya T, Ogura Y, Kai H, Kawaguchi A, Okawa S, Hirohama M et al TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility. Front Microbiol [Internet] 30 nov 2022 [cit\u00e9 30 sept 2025];13. Disponible sur: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2022.943877\/full","DOI":"10.3389\/fmicb.2022.943877\/full"},{"key":"11442_CR15","doi-asserted-by":"crossref","unstructured":"Yaghoobi A, Lord JS, Rezaiezadeh JS, Yekaninejad MS, Amini M, Izadi P (2023) TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population. PLOS ONE. 16 f\u00e9vr. ;18(2):e0281750","DOI":"10.1371\/journal.pone.0281750"},{"key":"11442_CR16","doi-asserted-by":"publisher","first-page":"100930","DOI":"10.1016\/j.mgene.2021.100930","volume":"29","author":"V Ravikanth","year":"2021","unstructured":"Ravikanth V, Sasikala M, Naveen V, Latha SS, Parsa KVL, Vijayasarathy K et al (2021) A variant in TMPRSS2 is associated with decreased disease severity in COVID-19. Meta Gene 1 Sept 29:100930","journal-title":"Meta Gene 1 Sept"},{"issue":"4","key":"11442_CR17","first-page":"410","volume":"71","author":"HA Garc\u00eda-Perdomo","year":"2018","unstructured":"Garc\u00eda-Perdomo HA, Chaves MJ, Osorio JC, Sanchez A (2018) Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis. Cent Eur J Urol 71(4):410\u2013419","journal-title":"Cent Eur J Urol"},{"key":"11442_CR18","doi-asserted-by":"publisher","unstructured":"Sekiya T, Ogura Y, Kai H, Kawaguchi A, Okawa S, Hirohama M et al TMPRSS2 gene polymorphism common in East Asians confers decreased COVID-19 susceptibility. Front Microbiol [Internet] 30 nov 2022 [cit\u00e9 29 juill 2025];13. Disponible sur: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2022.943877\/full","DOI":"10.3389\/fmicb.2022.943877\/full"},{"key":"11442_CR19","doi-asserted-by":"publisher","unstructured":"Bugoye FC, Torrorey-Sawe R, Biegon R, Dharsee N, Mafumiko F, Kibona H et al Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management. Front Oncol [Internet] 17 mars 2025 [cit\u00e9 29 juill 2025];15. Disponible sur: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/https:\/\/doi.org\/10.3389\/fonc.2025.1521204\/full","DOI":"10.3389\/fonc.2025.1521204\/full"},{"issue":"4","key":"11442_CR20","first-page":"94","volume":"4","author":"SJJ Powell","year":"2012","unstructured":"Powell SJJ, Conley-LaComb K, Chinni MK (2012) TMPRSS2-ERG fusion gene expression in prostate tumor cells and its clinical and biological significance in prostate cancer progression. J Cancer Sci Ther 26 Avr 4(4):94\u2013101","journal-title":"J Cancer Sci Ther 26 Avr"},{"issue":"12","key":"11442_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1210\/me.2013-1098","volume":"27","author":"L Clinckemalie","year":"2013","unstructured":"Clinckemalie L, Spans L, Dubois V, Laurent M, Helsen C, Joniau S et al (2013) Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element. Mol Endocrinol d\u00e9c 27(12):2028\u20132040","journal-title":"Mol Endocrinol d\u00e9c"},{"issue":"2","key":"11442_CR22","first-page":"272","volume":"53","author":"AAK Altaee","year":"2022","unstructured":"Altaee AAK, RECURRENT OF TMPRSS2 GENETIC POLYMORPHISM AND ITS ROLE IN IRAQI PATIENTS WITH PROSTATE CANCER. IRAQI JOURNAL OF AGRICULTURAL SCIENCES (2022) 29 Avr 53(2):272\u2013277","journal-title":"29 Avr"},{"issue":"3","key":"11442_CR23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1464-410X.2010.09522.x","volume":"107","author":"VN Giri","year":"2011","unstructured":"Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DYT, Boorjian SA et al (2011) Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of High-Risk men: effect of TMPRSS2 Met160Val. BJU Int f\u00e9vr 107(3):466\u2013470","journal-title":"BJU Int f\u00e9vr"},{"issue":"2","key":"11442_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/pros.24635","volume":"84","author":"RDS Menezes","year":"2024","unstructured":"Menezes RDS, Dornas MC, Campos CFF, Rodeiro DB, Carrerette FB, Oliveira RV et al (2024) Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ. Prostate f\u00e9vr 84(2):166\u2013176","journal-title":"Prostate f\u00e9vr"},{"key":"11442_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/RRU.S401131","volume":"15","author":"SM Warli","year":"2023","unstructured":"Warli SM, Warli MH, Prapiska FF (2023) PCA3 and TMPRSS2: ERG urine level as diagnostic biomarker of prostate cancer. RRU 5 Mai 15:149\u2013155","journal-title":"RRU 5 Mai"},{"key":"11442_CR26","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0571","author":"V Mollica","year":"2020","unstructured":"Mollica V, Rizzo A, Massari F (2020) The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol. https:\/\/doi.org\/10.2217\/fon-2020-0571","journal-title":"Future Oncol"},{"issue":"5","key":"11442_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.48193\/revistamexicanadeurologa.v78i5.136","volume":"78","author":"HA Garc\u00eda-Perdomo","year":"2018","unstructured":"Garc\u00eda-Perdomo HA, Zamora-Segura BD, S\u00e1nchez A (2018) Frequency of allelic variants of the TMPRSS2 gene in a prostate cancer-free Southwestern Colombian population. Rev Mex Urol 78(5):354\u2013358.","journal-title":"Rev Mex Urol"},{"issue":"2","key":"11442_CR28","doi-asserted-by":"publisher","first-page":"103333","DOI":"10.1016\/j.retram.2022.103333","volume":"70","author":"A David","year":"2022","unstructured":"David A, Parkinson N, Peacock TP, Pairo-Castineira E, Khanna T, Cobat A et al (2022) A common TMPRSS2 variant has a protective effect against severe COVID-19. Curr Res Translational Med 1 Mai 70(2):103333","journal-title":"Curr Res Translational Med 1 Mai"},{"key":"11442_CR29","doi-asserted-by":"crossref","unstructured":"Beheshti Shirazi SS, Sakhaee F, Sotoodehnejadnematalahi F, Zamani MS, Ahmadi I, Anvari E, et al. (2022) rs12329760 polymorphism in transmembrane serine protease 2 gene and risk of coronavirus disease 2019 mortality. BioMed Research International 2022:7841969.","DOI":"10.1155\/2022\/7841969"},{"issue":"5","key":"11442_CR30","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1007\/s11033-021-06390-1","volume":"48","author":"IS Mahmoud","year":"2021","unstructured":"Mahmoud IS, Jarrar YB (2021) Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges. Mol Biol Rep 1 Mai 48(5):4667\u20134675","journal-title":"Mol Biol Rep 1 Mai"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11442-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11442-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11442-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:02:37Z","timestamp":1768359757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11442-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11442"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11442-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients consented to the publication of the presented results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study adhered to ethical standards, with patient consent obtained, and approval granted by the Committee of Biomedical Research Ethics in Morocco (Ethics no. 3\/2018, dated April 30, 2018). Free and informed consent was obtained from all patients involved in this research and the confidentiality of their personal information was well-respected according to ethical rules.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"282"}}